迅遊科技(300467.SZ)擬回購註銷58.5萬股限制性股票及452.9萬份股票期權
格隆匯11月29日丨迅遊科技(300467.SZ)公佈,由於宏觀經濟及市場環境變化,公司股票價格發生了較大的波動,繼續推進2017年股票期權與限制性股票激勵計劃將難以達到預期的激勵目的和激勵效果,本着從公司長遠發展和員工切身利益出發,經審慎考慮,公司決定終止實施本次股權激勵計劃,並註銷55名激勵對象尚未行權的452.9萬份股票期權,回購註銷5名激勵對象已獲授但尚未解除限售的58.5萬股限制性股票。
本次回購註銷限制性股票將涉及公司註冊資本減少,公司註冊資本將由22334.8069萬元變更為22276.3069萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.